CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 91995-92353 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T734","span":{"begin":0,"end":358},"obj":"Sentence"},{"id":"T9141","span":{"begin":0,"end":358},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tuberculosis: fast forward to new approaches S17 The broad introduction of monoclonal antibodies to CD20 and CD52 and of nucleoside analogs into the treatment of patients with B-or T-cell lymphomas has lead to long-term depletion of B cells, eventually associated with decreasing levels of serum immunoglobulins, and T-cell deficiency lasting for many years."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T292","span":{"begin":0,"end":358},"obj":"Sentence"}],"text":"Tuberculosis: fast forward to new approaches S17 The broad introduction of monoclonal antibodies to CD20 and CD52 and of nucleoside analogs into the treatment of patients with B-or T-cell lymphomas has lead to long-term depletion of B cells, eventually associated with decreasing levels of serum immunoglobulins, and T-cell deficiency lasting for many years."}

{"project":"Epistemic_Statements","denotations":[{"id":"T190","span":{"begin":0,"end":358},"obj":"Epistemic_statement"}],"text":"Tuberculosis: fast forward to new approaches S17 The broad introduction of monoclonal antibodies to CD20 and CD52 and of nucleoside analogs into the treatment of patients with B-or T-cell lymphomas has lead to long-term depletion of B cells, eventually associated with decreasing levels of serum immunoglobulins, and T-cell deficiency lasting for many years."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T83","span":{"begin":181,"end":197},"obj":"Phenotype"}],"attributes":[{"id":"A83","pred":"hp_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/HP_0012190"}],"text":"Tuberculosis: fast forward to new approaches S17 The broad introduction of monoclonal antibodies to CD20 and CD52 and of nucleoside analogs into the treatment of patients with B-or T-cell lymphomas has lead to long-term depletion of B cells, eventually associated with decreasing levels of serum immunoglobulins, and T-cell deficiency lasting for many years."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T86","span":{"begin":290,"end":295},"obj":"Body_part"}],"attributes":[{"id":"A86","pred":"uberon_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Tuberculosis: fast forward to new approaches S17 The broad introduction of monoclonal antibodies to CD20 and CD52 and of nucleoside analogs into the treatment of patients with B-or T-cell lymphomas has lead to long-term depletion of B cells, eventually associated with decreasing levels of serum immunoglobulins, and T-cell deficiency lasting for many years."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T338","span":{"begin":0,"end":12},"obj":"Disease"},{"id":"T339","span":{"begin":181,"end":197},"obj":"Disease"},{"id":"T340","span":{"begin":317,"end":334},"obj":"Disease"},{"id":"T21786","span":{"begin":0,"end":12},"obj":"Disease"},{"id":"T19615","span":{"begin":181,"end":197},"obj":"Disease"},{"id":"T80343","span":{"begin":317,"end":334},"obj":"Disease"}],"attributes":[{"id":"A338","pred":"mondo_id","subj":"T338","obj":"http://purl.obolibrary.org/obo/MONDO_0018076"},{"id":"A339","pred":"mondo_id","subj":"T339","obj":"http://purl.obolibrary.org/obo/MONDO_0015760"},{"id":"A340","pred":"mondo_id","subj":"T340","obj":"http://purl.obolibrary.org/obo/MONDO_0001222"},{"id":"A14555","pred":"mondo_id","subj":"T21786","obj":"http://purl.obolibrary.org/obo/MONDO_0018076"},{"id":"A57614","pred":"mondo_id","subj":"T19615","obj":"http://purl.obolibrary.org/obo/MONDO_0015760"},{"id":"A87492","pred":"mondo_id","subj":"T80343","obj":"http://purl.obolibrary.org/obo/MONDO_0001222"}],"text":"Tuberculosis: fast forward to new approaches S17 The broad introduction of monoclonal antibodies to CD20 and CD52 and of nucleoside analogs into the treatment of patients with B-or T-cell lymphomas has lead to long-term depletion of B cells, eventually associated with decreasing levels of serum immunoglobulins, and T-cell deficiency lasting for many years."}